MCAT and chronic obstructive pulmonary disease: We have previously observed that an investigational Hi vaccine containing the same components but without Mcat protein had an estimated vaccine efficacy of 13.3% against moderate/severe exacerbations in a clinical trial of adults with COPD [11].